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Background: The apicomplexan parasite Toxoplasma gondii can infect and replicate in virtually any nucleated cell
in many species of warm-blooded animals; T. gondii has elaborate mechanisms to counteract host-cell apoptosis in
order to maintain survival and breed in the host cells.
Methods: Using microarray profiling and a combination of conventional molecular approaches, we investigated the
levels of microRNAs (miRNAs ) in human macrophage during T. gondii infection. We used molecular tools to
examine Toxoplasma-upregualted miRNAs to revealed potential signal transducers and activators of transcription
3(STAT3) binding sites in the promoter elements of a subset of miRNA genes. We analysed the apoptosis of human
macrophage with the functional inhibition of the STAT3-binding miRNAs by flow cytometry.
Results: Our results demonstrated differential alterations in the mature miRNA expression profile in human
macrophage following T. gondii infection. Database analysis of Toxoplasma-upregulated miRNAs revealed potential
STAT3 binding sites in the promoter elements of a subset of miRNA genes. We demonstrated that miR-30c-1,
miR-125b-2, miR-23b-27b-24-1 and miR-17 ~ 92 cluster genes were transactivated through promoter binding of the
STAT3 following T. gondii infection. Importantly, functional inhibition of selected STAT3-binding miRNAs in human
macropahges increased apoptosis of host cells.
Conclusions: A panel of miRNAs is regulated through promoter binding of the STAT3 in human macrophage and
these miRNAs are involved in anti-apoptosis in response to T. gondii infection.
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As a typical intracellular protozoan parasite of warm-
blooded vertebrates, Toxoplasma gondii has elaborate
mechanisms to counteract host-cell apoptosis in order to
maintain survival and breed in the host cells [1-4]. Upon
invasion of T. gondii, the parasite uses a specialized set of
secretory organelles to inject parasite-derived effector
molecules into its host cell [5]. These effector molecules
can specifically modulate host cell gene expression to im-
prove the ability of the parasite to infect and proliferate,
via inhibition of host immune responses, and change their
gene expression to escape immunologic surveillance [6].* Correspondence: 271313069@qq.com
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stated.Quantitative analysis of the host mRNAs and proteome
during T. gondii infection showed that upwards of 15% of
mRNAs and upregulation of 213 protein spots display al-
tered abundance relative to uninfected cells, including cru-
cial mRNAs and proteins that were associated with the
apoptotic pathway [7,8].
MicroRNAs (miRNAs) are endogenous small (19 ~ 24 nt
long) noncoding RNAs that regulate gene expression in a
sequence specific manner. This is primarily accomplished
through binding to 3′UTR of target mRNAs, either target-
ing the transcripts for degradation or blocking their trans-
lation [9]. However, molecular mechanisms underlying
miRNA gene transcriptional regulation are largely unclear.
Recent studies on expression of miRNA genes have re-
vealed potential transcriptional regulation by transcription
factors, such as p53, NF-κB and MAPK [6,10,11]. Recently,. This is an Open Access article distributed under the terms of the Creative
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(STAT) signaling pathway has emerged as a major target of
exploitation by Toxoplasma. Infection of mouse bone
marrow-derived macrophage induces rapid and sustained
activation of signal transducers and activators of transcrip-
tion 3(STAT3) [12,13]. Although a number of miRNAs
have been shown to be important components of the
STAT3 in various cell types [14-16], the potential inter-
action between miRNAs and STAT3 in human macro-
phage, in which the activation of STAT3 by infection with
Toxoplasma may result in distinct biological consequences,
has not yet been established.
In this study, we provide evidence that Toxoplasma-host
cell interactions counteract the death of parasite-infected
cells through upregulation of STAT3-binding miRNAs in
human macrophage. The array analysis of miRNA expares-
sion revealed significant alterations in miRNA expression
in human macrophage following Toxoplasma infection.
We report here that STAT3 mediated a prosurvival path-
way by upregulation the miRNAs, leading to inhibition of
host cells with Toxoplasma infection. Thus, the role of
STAT3-binding miRNAs is postulated to be an important
apparatus in Toxoplasma biology.
Methods
Parasites
The T. gondii strain, named TgCtwh3 with the atypical
genotype China 1 (ToxoDB#9) and high virulence to mice
as previously identified [17,18], was kept in the laboratory
by mouse passage. Tachyzoites were maintained by twice
weekly passage on HF (human fibroblast cells) in culture
medium (DMEM with 10% FCS, 100U/ml penicillin and
100 μg/ml streptomycin, GIBCO).
Human macrophage separation, culture and
determination
Human PBMCs for in vitro parasite infection assays were
isolated from the whole blood of 6 healthy individuals with
written informed consent (2 female and 4 males, mean
age 22+/−3 yrs). Ethical permission was obtained from the
Institutional Review Board (IRB) of the Institute of Bio-
medicine at Anhui Medical University (Permit Number:
AMU26-08610), which records and regulates all research
activities in the school. Heparinized fresh whole blood
(10 IU heparin/ml) was centrifuged against a Ficoll-Paque
density gradient (density:1.077 g/ml; Solarbio) for 30 min
at 2500 rpm. Peripheral blood mononuclear cells (PBMCs)
were aspirated and washed in PBS before culture. The
PBMCs were cultured at 37°C in 5% CO2 atmosphere at a
density of 1 × 106 cells/well in DMEM medium supple-
mented with 10% FCS. PBMCs were used as host macro-
phage after induction to differentiate with 1000U/ml
recombinant human GM-CSF (Preprotech) for 48 h. Mac-
rophages were stained with FITC-conjugated anti-CD14to determine the purity of CD14+ cells. Control and in-
fected cells were stained with Wright-Giemsa for 8 min,
rinsed with distilled water and air dried. Cell morphology
was observed by light microscopy. THP-1 cells (Cell bank,
CAS) were cultured in DMEM medium supplemented
with 10% FCS, and treated with 20 nmol of phorbol 12-
myristate 13-acetate (PMA, Sigma) to induce THP-1 cells
differentiation into macrophage-like THP-1 cells [19].
MiRCURYTM LNA array analysis of miRNAs
The Exiqon (Vedbaek, Denmark) mercury LNA microRNA
arrays service were used to process the samples were used.
Briefly, human macrophage were exposed to TgCtwh3 for
24 h. Total RNAs from macrophage were harvested using
TRIzol (Invitrogen) and miRNeasy min kit (QIAGEN) ac-
cording to manual instructions. After having passed RNA
quantity measurement using the NanoDrop 1000, the sam-
ples were labeled using the miRCURYTM Hy3TM/Hy5TM
Power labeling kit and hybridized on the miRCURYTM
LNA Array (v.16.0). Following the washing steps the slides
were scanned using the Axon GenePix 4000B microarray
scanner (Axon Instruments, Foster City, CA). Scanned im-
ages were then imported into GenePix Pro 6.0 software
(Axon) for grid alignment and data extraction. Repli-
cated miRNAs were averaged and miRNAs that inten-
sities are ≥50 in all samples were chosen for calculating
a normalization factor. Expressed data were normalized
using the Median normalization. After normalization,
differentially expressed miRNAs were identified through
Volcano Plot filtering. Hierarchical clustering was per-
formed using MEV software (v4.6, TIGR).
qRT-PCR analysis
Macrophage were exposed to TgCtwh3 or LPS (1 μg/ml)
as a control for different duration (6,12 and 24 h). For
qPCR analysis of mature miRNAs, total RNA was reverse-
transcribed from 0.05 μg total RNAs and determined with
All-in-oneTM miRNA qRT-PCR detection kit (GeneCo-
poeia) by Applied Biosystems 7500 real-time PCR System
(Applied Biosystems). The specific primers used in this re-
action were as follows: miR-19b; miR-19a; miR-20a; miR-
27b; miR-30c; miR-125 (all from GeneCopoeia).
For analysis of pri-miRNAs, total RNA was isolated from
cells with Trizol reagent (Ambion). RNAs were treated with
DNA-free TM Kit (Ambion) to remove any remaining
DNA. Comparative real-time PCR was performed by using
the SYBR Green PCR Master Mix (Applied Biosystems).
Specific primers for pri-miRNAs were listed in Additional
file 1: Table S1.
All reactions were run in triplicate. The Ct values
were analyzed using the comparative Ct (ΔΔCt)
method. Normalization was performed by using the
small housekeeping U6 relative to the control (non-
treated cells).
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To obtain total cellular lysates, transfected cells and
controls were lysed in ice-cold cell lysis buffer [20 nM tris,
250 mM NaCl, 2 Mm EDTA, 0.1% Triton X-100,
0.01 mg/ml aprotinin, 0.003 mg/ml leupetin, 0.4 mM
phenylmethylsulfonyl fluoride, and 4 mM NaVO4]
(Sigma). The protein concentration was determined
with the Bradford protein assay kit (BESTBIO) using a
c-globulin standard curve. Proteins were separated by
standard SDS-PAGE and transferred onto nitrocellulose
membranes (Beyotime). Nonspecific binding sites were
blocked using 5% dry skimmed milk, 0.2% Tween-20 in
PBS (pH 7.4) for overnight at 4°C and then incubated with
primary antibodies to STAT3 and GAPDH (Proteintech).
Plasmid construction and transcriptional reporter assays
For construction of a constitutively active form of human
STAT3, named STAT3-C, the amino acid residues at
A661 and N663 were mutated to cysteine [20], the se-
quences were chemically synthesized and cloned into
pEZ-M02 (GeneCopeia). STAT3-WT:3′-GATGCTACCA
ATATCCTGGT-5′; STAT3-C: 3′-GATTGCACCTGC
ATCCTGGT-5′pEZ-M02-STAT3-WT (200 ng), pEZ-
M02-STAT3-C (300 ng) or empty vector was individually
cotransfected into THP-1 cells, together with appropri-
ate miR-17 ~ 92 gene cluster promoter reporter plas-
mids (200 ng) by using Effectene Transfection Reagent
(Qiagen). In each transfection, cells were also cotrans-
fected with pRL-CMV (Renilla luciferase reporter plas-
mid, Promega). Firefly and Renilla luciferases activity
was assayed using a Dual-Luciferase Reporter Assay
System (Promega). The magnitude of activation values
was measured relatively to the levels of Firefly luciferase
activity in THP-1 cells transfected with empty vectors
and normalized by Renilla luciferase activity. A mutation
was introduced into the STAT3 binding site (STAT3-BR-1)
using the following primers: sense 5′ - TAT GTC CTT
GAG AAT TCC GGA ATT TCC TG - 3′; anti-sense 5′ -
TCT CAA GGA CATAAT TGT TAA AAG TGA GG - 3′
(alterations underlined) [20]. The correct sequence of each
insert was confirmed by sequencing. SiRNA. THP-1 cells
were transiently transfected with STAT3 siRNA or siRNA-
control (40 nM, Santa Cruz) for 24 h using SuperFectin II
in vitro siRNA Transfection Reagent (PuFei Biotech) ac-
cording to the manufacturer’s protocols.
Flow cytometry
Cell death following induction of apoptosis and infec-
tion with Toxoplasma was quantified by flow cytome-
try. Annexin-V/propidium iodide (PI) double assay was
performed using the Annexin V-EGFP Apoptosis De-
tection Kit (BESTBIO). Infected or non-infected mac-
rophages were washed twice with PBS. 1 × 106 cells
were resuspended in 400 μl binding buffer and stainedwith 5 μl Annexin V-EGFP according to the manual’s rec-
ommendations. 10 μl PI was added and allowed to incu-
bate with cells for 5 min at 4°C in the dark. Then cells
were analyzed using a FACSCalibur flow cytometer (BD
Biosciences).Results
Toxoplasma infection induces alterations in miRNA
expression in macrophage in vitro
Human macrophage were separated from whole blood
and cultured after 48 h (Additional file 2: Figure S1A).
Cells were stained with FITC-conjugated CD14 anti-
body and subjected to flow cytometry to determine the
purity of macrophage. The percentages of CD14+ cells
were 94.7 ± 0.60% after induction with GM-CSF in
PBMCs (Additional file 2: Figure S1B). To determine if
the parasites could infect macrophage, cells of control
and infected cells were examined using Wright-Giemsa
(Additional file 2: Figure S1C). After 24 h of infection,
the tachyzoites can be seen in the cytoplasm of macro-
phage (Additional file 2: Figure S1D).
To globally assess miRNA expression in human
macrophage following Toxoplasma infection, we per-
formed a microarray analysis of mature miRNA expres-
sion in macrophage. We profiled the levels of miRNAs
extracted at 24 h from uninfected and tachyzoites-
infected human macrophage using miRCURYTM LNA
Array (v.16.0). A total of 17 miRNAs were upregulated
(p< = 0.20) following Toxoplasma infection (Figure 1A).
Of the miRNAs expressed, miR-20a, miR-125, miR-19a,
miR-19b, miR-27b and miR-30c expression were signifi-
cantly increased (p< = 0.05) in human macropahge after
exposure to Toxoplasma infection for 24 h (Figure 1A).
To validate the microarray data and to specifically
measure the effects of Toxoplasma infection on miR-
NAs, qRT-PCR analysis using primers for mature miR-
NAs was performed to assess the kinetics of miRNAs in
human macrophage following Toxoplasma infection.
Increased expression of miR-20a, miR-125, miR-19a,
miR-19b, miR-27b and miR-30c were noted in human
macrophage at 6 h and 12 h postinfection, the abundance
of these miRNAs significantly increased by ~23.5-fold at
24 h postinfection. The qRT-PCR analysis of miRNAs
was also performed on human macrophage treated
with LPS (1 mg/ml for 6 h, 12 h and 24 h) in order to de-
termine the specificity of upregulation and expression
of these miRNAs in Toxoplasma-infected cells. The re-
sults showed that increased expression of miRNAs was
identified in Toxoplasma-infected cells but not in cells
exposed to LPS at 24 h (p < =0.05; Figure 1B). No LPS
contamination in the Toxoplasma preparation was de-
tected using the Limulus Amebocyte Lysate (LAL) test
kit (Bio-Whittaker) (data not shown).
Figure 1 Expression profiling of mature miRNAs in macrophage following Toxoplasma infection and LPS stimulation. (A) miRNA
expression profile in human macrophage following Toxoplasma infection. The left panel shows a heat-map of selected miRNAs indicating alteration in
expression in macrophages following Toxoplasma infeciton.The filtered miRNA array data were subjected to unsupervised hierarchical clustering
analysis. The metric was set as the Euclidean distance. The right panel shows expression miRNAs in macrophage following Toxoplasma infection. The
fold change contains the ratio of mormalized intensities between Toxoplasma-infected macrophage (Group T) and non-infected macrophage (Group
C). The p values are from the T test. (B) Altered expression of selected miRNAs confirmed by qRT-PCR. The amount of mature miRNAs was obtained by
normalizing to the level of snRNA RNU6B in the samples. Graphics indicate those miRNAs showing an increased expression (including those significant
change when p< = 0.05) in cells after treatment with LPS (n = 3) or exposure to Toxoplasma (n = 3). *, p,0.05 vs. the non-treated control.
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macropahge following Toxoplasma infection reveals
potential STAT3 binding sites In their promoter elements
Differential alterations in the mature miRNA expression
profile of Toxoplsma-infected human macropahge suggest
that miRNA gene expression is finely controlled in macro-
pahge in response to Toxoplasma infection. One potential
mechanism for selectively altering miRNA levels is through
activation of distinct intracellular signaling pathways and
nuclear transcription factors. Based on TFSEARCH (http://
www.cbrc.jp/research/db/TFSEARCH.html) and MOTIF
(http://motif.genome.jp/) database searches, many of these
miRNA genes have putative STAT3 binding sites in their
potential promoter elements (Table 1). We hypothesized
that activation of the STAT3 pathway is involved in the
transcription of selected miRNAs upregulated by Toxo-
plasma. Several miRNAs upregulated in human macro-
pahge following Toxoplasma infection are cluster
miRNAs; e.g., miR-19a, miR-19b and miR-20a are from
the miR-17 ~ 92 gene cluster. So we focused ondetermining whether STAT3 binds to the promoter and
transactivates the miRNA genes upregulated by Toxo-
plasma infection in human macropahge.
Differential expression of primary transcripts of Toxoplasma-
upregulated mature miRNAs in human macrophage
We then analyzed the kinetics of alterations of the primary
transcripts (pri-miRNAs) for select mature miRNAs upreg-
ulated by Toxoplasma as listed in Table 1. Human macro-
pahge were exposed to Toxoplasma for various periods of
time and pri-miRNAs of interests were quantified
by qRT-PCR (primers listed in Additional file 1: Table
S1). Expression of pri-miR-30c-1, pri-miR-125b-2, pri-
miR-23b-27b-24-1 and pri-miR-17 ~ 92 showed a time-
dependent increase in cells following Toxoplasma infection
(p< = 0.05, Figure 2). In contrast, for pri-miR-30c-2, pri-
miR-125b-1, no significant increase was detected in cells
after exposure to Toxoplasma infection (p > 0.05, Figure 2),
suggesting a differential expression of the primary tran-
scripts of Toxoplasma-upregulated miRNAs.
Table 1 Analysis of Toxoplasma-upregulated miRNAs in human macrophage reveals potential transactivation of their
genes by STAT3
Mature miRNAs Chromosome (strand) Host gene Promoter Median (range) STAT3 binding score*
Start coordinates End coordinates
miR-30c 1(+) miR-30c-1 41173077 41177703 759(759–759)
miR-30c-2
miR-27b 9(+) miR-23b-24-1 97763989 97769651 256(256–256)
miR-125 21(+) miR-125b-1 17564208 17569306 348(348–348)
miR-125b-2
miR-19a 13(+) miR-17 ~ 92 91995074 92000073 943 (943–943)
miR-19b
miR-20a
*MiRNAs with the highest STAT3 bindings scores according to the ENCODE ChIP-seq database are depicted.
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transcription of select miRNA genes induced by
Toxoplasma in human macrophage
To test whether STAT3 is involved in Toxoplasma-in-
duced transactivation of pri-miR-17 ~ 92 we exposed hu-
man macrophage to Toxoplasma infection in the presence
of siRNA-STAT3, that prevents expression of the STAT3
(Figure 3A). siRNA-STAT3 blocked the Toxoplasma-in-
duced increase of pri-miR-17 ~ 92 (Figure 3B). To further
test the potential transactivation of miR-17 ~ 92 gene by
STAT3, luciferase reporter gene constructs was used.
Toxoplasma infection increased luciferase activity in cells
transfected with the luciferase constructs that encompassed
the binding site for STAT3 in the promoter region of miR-
17 ~ 92 gene. A mutant of the STAT3 binding site blocked
Toxoplasma-induced luciferase activity (Figure 3C). In
addition, siRNA-STAT3 significantly inhibited the increaseFigure 2 Differential expression of primary transcripts of Toxoplasma
macrophage were exposed to Toxoplasma for 6 h, 12 h and 24 h and primary
The amount of pri-miRNAs was obtained by normalizing to the level of GAPD
infected samples relative to the control uninfected samples and representativof luciferase activity induced by Toxoplasma infection
(Figure 3D). Moreover, STAT3-associated transactivation of
the miR-17 ~ 92 promoter was also confirmed by the up-
regulation of luciferase activity after STAT3 overexpression
in the cells (Figure 3D). Together, these data demonstrate
that STAT3 binding to the promoter element of the miR-
17 ~ 92 gene mediates miRNAs (miR-17-5p, miR-18a, miR-
19a, miR-20a, miR-19b and miR-92a) upregulation in
human macrophage in response to Toxoplasma infection.
Functional inhibition of selected STAT3-dependent
miRNAs increase apoptosis of human macrophage with
Toxoplasma infection
To test whether miRNAs are involved in human macro-
phage inhibition of apoptosis with Toxoplasma infection,
we assessed apoptosis over time in cultured macrophage
transfected with various anti-miRs thereby inhibiting-upregulated mature miRNAs in human macrophage. Human
transcripts (pri-miRNAs) of select miRNAs were quantified by qRT-PCR.
H in the samples. Data are expressed as the amount of pri-miRNAs in the
e of three independent experiments. *, p,0.05 vs. the non-infected control.
Figure 3 Promoter binding of STAT3 transactivates miR-17 ~ 92 gene to increase mature miR-17 ~ 92 miRNAs expression following
Toxoplasma infection. (A) Western blot analysis showing stable knock-down of STAT3 by siRNA. (B) STAT3-dependent upregulation of
pri-miR-17 ~ 92 in human macrophage following Toxoplasma infection. Data are presented as the relative expression level of pri-miR-17 ~ 92 in
THP-1 cells following Toxoplasma infection in the presence or absence of siRNA as assessed by qRT-PCR. (C) A schematic illustration of
pGL-based reporter constructs was used in dual luciferase assays to examine the transcriptional activity of the STAT3-BR in response to TgCtwh3
infection. Dotted lines indicated deleted region. (D) THP-1 cells were cotransfected with the indicated reporter constructs and Renilla luciferase
plasmids. Twenty-four hours later, transcriptional activity was determined by luciferase assays. THP-1 cells with or without STAT3 knock-down
by siRNA were cotransfected with the indicated reporter constructs and Renilla luciferase plasmids. Twenty-four hours later, cells were exposed
to TgCtwh3 for another 24 h, followed by measurement of reporter activity by using luciferase assays. *, p,0.05 vs. non-treated cells (in B) or
cells transfected with a control vector (in D) .Values are presented as mean ± SD (n =3 in A, B and D)
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MiRNA inhibitors are commercially available, chemically
modified single stranded nucleic acids designed to specif-
ically bind to and inhibit endogenous miRNAs. Cells were
transfected with specific anti-miRs (30 nM, Ambion) or a
mixture of anti-miRs to miR-17-5b and miR-20a (a total
of 30 nM with 15 nM for each), and then exposed to
Toxoplasma for 24 h. The percentages of parasite-positive
macrophage following exposure to Toxoplasma for 24 h
was similar in all cultures, to those transfected with the
specific anti-miRs (p > 0.05, Figure 4A), suggesting that
those transfected with anti-miRs did not affect the number
of parasite-infected macrophage. Cells transfected with
anti-miRs to miR-17-5b and miR-20a, as well as a mixture
of two anti-miRs, displayed a decreased the number of
Annexin V-/PI- macrophage (viable cells) as compared to
control cells. In addition, these anti-miRs increased the
number of Annexin V+/PI- macrophage (early apoptosis)
(p < = 0.05, Figure 4B).
Discussion
There is evidence that miRNAs play a critical role in the
regulation of apoptosis [21,22] A better understanding
miRNA expression changes in human macrophage follow-
ing Toxoplasma infection will provide new insights inmiRNA-associated apoptosis. we report significant alter-
ations in miRNA expression profiles in human macrophage
following Toxoplasma infection. Our analysis of miRNAs
upregulated by Toxoplasma in human macrophage re-
vealed that miR-30c-1, miR-125b-2, miR-23b-27b-24-1 and
miR-17 ~ 92 genes are transactivated via potential promoter
binding of the STAT3.
These data provide several insights relevant to miRNA
expression regulation in human macrophage following
Toxoplasma infection. First, transactivation of miRNA
genes that produce the same mature miRNA can be differ-
entially controlled. Specifically, both mir-125b-1 and mir-
125b-2 genes can produce mature miR-125b, but only
transactivation of mir-125b-2 gene was detected in cells
following Toxoplasma infection. In this study, we demon-
strated that promoter binding of the STAT3 is required
for transactivation of the miR-30c-1, miR-125b-2, miR-
23b-27b-24-1 and miR-17 ~ 92 genes in cells following
Toxoplasma infection. Given the complexity and variabil-
ity in the gene structure for each miRNA, it is obvious that
multiple mechanisms are involved in the transcriptional
regulation of human miRNA genes [23-25]. Therefore,
transcription of miRNA genes is expected to be a dynamic
process in response to the constant alterations in intracel-
lular signals. miRNA expression thus reflects the final
Figure 4 Functional inhibition of selected STAT3-dependent miRNAs in human macrophage increases apoptosis of cells in vitro. (A)
Percentages of parasite-positive macrophage (Wright-Giemsa stain as shown in Additional file 2: Figure S1) after transfection with specific
anti-miRs (black bars) or untreated (white bars). (B) Transfection of cells with anti-miRs on apoptosis of human macrophage for 24 h after initial
exposure to the parasite. Dot plots depict the amounts of macrophage stained with Annexin V and/or PI; numbers indicate percentages of cells in each
quadrant from a representative experiment. (C) Percentage of cells with Toxoplasma after transfected with anti-miR-17-5p, anti-miR-20a, or ant-miR-17-5p
and anti-miR-20a. *, p,0.05 vs. the non-transfected with Toxoplasma infection control.Values are presented as mean ± SD (n = 3 in A-B).
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miRNA transcription. In this regard, other transcription
factors, such as NF-kB, AP-1, c-myc, C/EBPa, may also be
involved in the transcriptional regulation of miRNA genes
in human macrophage in response to Toxoplasma infec-
tion. Future studies will focus on whether the other tran-
scription factors are involved in the Toxoplasma-induced
upregulation or downregulation of miRNA expression.
Secondly, transactivation of genes of cluster miRNAs or as
introns in other gene alleles may be controlled by the
same promoter element. Of note, miR-19b, miR-19a and
miR-20a are cluster gene miRNAs and co-transcribed with
a host gene, C13orf25 [26]. Toxoplamsa infection upregu-
lates expression of the mature forms of these three miR-
NAs, as well as pri-miR-17 ~ 92 and the host genetranscript, C13orf25. Our data are consistent with recent
studies demonstrating transcriptional control of genes that
code cluster miRNAs or that encode both miRNAs and
other host transcripts [25]. Finally, the miR-17 ~ 92 gene
appear to attenuate apoptotic responsiveness by targeting
several mRNAs encoding pro-apoptotic effectors and favor
progression from G1 to S-phase by targeting mRNAs that
encode negative regulators of the cell cycle [27,28]. In our
study, we found promotion of apoptosis of human
macrophage with Toxoplasma infection via inhibition of
miR-17 ~ 92 gene.
Previous investigation showed that a single amino acid
substitution in the kinase domain of Toxoplasma ROP16
in difference strains determined STAT3 activation between
type I and type II. Significantly, we found that TgCtwh3
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same amino acid substitution of the kinase domain of
ROP16 at 503 bp (503 L, data not shown) as that of
TGGT1 strain (503 L) with archetypical type I, which
might account for the identical way of activation to STAT3
as type I [12]. Although Toxoplasma can infect any kind of
nucleated cells, macrophage and related mononuclear
phagocytes are its preferred target in vivo, and the parasite
seems to have multiple ways of avoiding being killed
[29,30]. Therefore, macrophage-centric research is essential
to understand the basic strategies of the parasite-host
interaction [31]. miRNAs have been identified in both
mammalian and nonmammalian cells including virus and
parasites [32,33]. Toxoplasma could increased the levels of
miRNA in HFF cells [34], however, expression of miRNAs
in Toxoplasma has not yet been examined and whether
Toxoplsma-derived miRNAs can be localized in human
macrophage is unknown. Nevertheless, the probes used in
the microarray analysis in this study are human-miRNA
specific with minimal cross-interaction with known miR-
NAs from other species.
Conclusions
In summary, this first miRNA profiling in human macro-
phage in response to Toxoplasma infection in vitro re-
vealed significant alterations in cellular miRNA expression.
The mechanism by which Toxoplasma induces upregula-
tion of a panel of miRNAs in human macrophage involves
transactivation of miRNA genes through promoter binding
of the STAT3. In addition, functional inhibition of the up-
regulated miRNAs increases apopotosis of macrophage
with Toxoplasma infection thereby implicating these miR-
NAs in host cell help parasite survival. These data demon-
strate a better understanding of miRNA expression in
human macrophage following Toxoplasma infection will
play a critical role in inhibition of apoptosis of host cells
and it may provide new insights into relationship between
the intracellular parasite and its hose cells.
Additional files
Additional file 1: Table S1. Primers used for qRT-PCR.
Additional file 2: Figure S1. Determination of macrophage from PBMCs.
PBMCs-derived macrophage were separated from whole blood and stained
with FITC-conjugated CD14 antibody to determine the purity of macro-
phage. (A) PBMCs-derived macrophage under microscope (×200). (B) CD14
expression of PBMCs-derived macrophage. (C) PBMCs-derived macrophage
seen by microscopy (Wright-Giemsa, ×1000). (D) PBMCs-derived macro-
phage with TgCtwh3 for 24 h seen by microscopy (Wright-Giemsa, ×1000).
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